发明名称 Carrier for antibody purification, manufacturing method for same, and application for same
摘要 An object of the present invention is to provide a carrier on which Protein A has been immobilized, the Protein A having a specific amino acid sequence that permits the desorption of antibodies under mild pH conditions (specifically, pH 4.0 to 5.5) in which many antibodies do not undergo acid modification; and a manufacturing method for the carrier. An immobilization carrier (excluding an immobilization carrier having a monolith structure) on which a protein is adsorbed by electrostatic interaction, the protein consisting of an amino acid sequence represented by the general formula: R1-R2-R3-R4-R5-R6, wherein the part represented by R1-R2-R3 is used for immobilization on the immobilization carrier, wherein: the sequence represents a sequence from the amino-terminal side towards the carboxyl-terminal side; the sequence of the R2 part is the sequence of a Protein A mutant as a protein to be immobilized or a sequence in which 1 to 3 units of the sequence thereof were linked together, the Protein A mutant having characteristics of strongly binding to an antibody under neutral conditions and dissociating with the antibody bound under neutral conditions under weakly acidic conditions of pH 4.0 to 5.5.
申请公布号 US9534060(B2) 申请公布日期 2017.01.03
申请号 US201314406728 申请日期 2013.06.11
申请人 Osaka Soda Co., Ltd. 发明人 Iwakura Masahiro;Hirota Kiyonori;Otaka Seiji
分类号 C07K17/14;C07K1/22;C07K14/31;C07K16/06;B01D15/38;B01J20/286;B01J20/32 主分类号 C07K17/14
代理机构 Brinks Gilson & Lione 代理人 Brinks Gilson & Lione
主权项 1. An immobilization carrier, excluding an immobilization carrier having a monolith structure, onto which a protein is adsorbed by electrostatic interaction, the protein consisting of an amino acid sequence of the general formula: R1-R2-R3-R4-R5-R6, wherein R1-R2-R3 is used for immobilization on the immobilization carrier, wherein: the amino acid sequence is a sequence from the amino-terminal side towards the carboxyl-terminal side; R1 may be absent, and, if present, is Met; R2 is the sequence of a mutant protein of the A-domain of Protein A consisting of a sequence selected from SEQ ID NOS: 4 to 7, or a sequence wherein 1 to 3 units of the sequence of the mutant protein of the A-domain of the Protein A consisting of a sequence selected from of SEQ ID NO: 4 to 7 are linked together; R3 may be absent, and, if present, is a spacer sequence consisting of 1 to 10 glycine residues; R4 is a sequence consisting of 2 residues of amino acids: cysteine-X, wherein X is alanine or an amino acid residue other than alanine and cysteine; R5 may be absent, and, if present, is a sequence of 1 to 10 amino acid residues consisting of aspartic acid, glutamic acid, or a combination thereof capable of rendering the isoelectric point of the protein consisting of the amino acid sequence of the general formula: R1-R2-R3-R4-R5-R6 on the acidic side; and R6 is an affinity tag sequence for the purification of proteins.
地址 Osaka-shi JP